Shares of Hormel Foods Corporation (NYSE: HRL) stayed red on Monday. The stock has dropped 5% over the past three months. The branded food company is slated to report its first quarter 2024 earnings results on Thursday, February 29, before markets open. Here’s a look at what to expect from the earnings report:
Revenue
Analysts are projecting revenues of $2.92 billion for the first quarter of 2024. This compares to sales of $3 billion reported in the same quarter last year. In the fourth quarter of 2023, net sales decreased 3% year-over-year to $3.2 billion.
Earnings
The consensus estimate for EPS in Q1 2024 is $0.34, which compares to EPS of $0.40 reported in Q1 2023. In Q4 2023, adjusted EPS amounted to $0.42.
Points to note
Hormel faced a challenging year in 2023, with pressure in its Retail and International businesses offsetting momentum in the Foodservice segment. The company has been navigating an environment with challenges like slowing consumer demand, inflationary pressures, and headwinds in the turkey business.
In fiscal year 2024, Hormel expects its Foodservice business to see continued growth. It expects to gain traction in key categories such as bacon, pepperoni, prepared proteins, and turkey. This bodes well for the first quarter.
The Retail business is anticipated to see sales growth in categories like bacon, convenient meals and proteins, and snacking, in the coming fiscal year and this could benefit the first quarter as well.
Last year, the company’s International business was impacted by softness in China, weak commodity markets, and higher-than-expected elasticities on its branded export business. Hormel expects these challenges to persist in the first quarter of 2024, with a steady recovery anticipated from the second quarter.
With regards to the bottom line, Hormel expects the impacts from lower turkey markets, lower retail volumes, and softness in China to cause a drop in earnings during the first half of 2024, with the pressures most pronounced in Q1.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform that digitalizes the retail pharmacy experience. The company has a growing network of suppliers and partnerships with independent
Earnings Preview: Walmart (WMT) expected to report sales and profit gains in Q1
Over the years, Walmart Inc. (NYSE: WMT) has constantly diversified while maintaining its dominance in the retail world. The company is preparing to report financial results for the first three
What to look for when Take-Two Interactive Software (TTWO) reports Q4 2024 earnings results
Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) stayed red on Thursday. The stock has dropped 14% over the past three months. The gaming company is scheduled to report its
